Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

AIM ImmunoTech Stock Today: AIM Surges 44% on Massive Volume After Patent Approval and Cancer Trial Progress

Shares of AIM ImmunoTech Inc. (NYSE American: AIM) rocketed higher Wednesday, closing at $1.02, up 31 cents or 43.66%, on extraordinarily heavy trading volume exceeding 183 million shares as investors reacted to a key patent milestone and ongoing clinical advancements in its lead drug Ampligen for pancreatic cancer.

International Business Times

Your Mounjaro Knockoff Could Kill You

Boston Medical Group last year warned that purchasing Ozempic and other weight-loss drugs from unauthorized sellers is risky business, as their products can be fake or of poor quality. The FDA had already shut down more than 250 fake websites for selling counterfeit weight loss drugs or other medications.

International Business Times

Pharma Executives Sentenced to Decades for $92M Black‑Market HIV Drug Scheme

Pharma executives sentenced to decades in prison after a $92M black-market HIV drug scheme exposed illegal buybacks, unsafe resale practices, and fraud.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Ozempic Controversy Deepens as FDA Accuses Novo Nordisk of Failing to Report Patient Deaths, One Linked To Suicide

Novo Nordisk faces FDA scrutiny for failing to report Ozempic-linked deaths, highlighting systemic issues in safety reporting. Learn about the implications for patient safety and ongoing legal challenges.

International Business Times UK

One of Britain’s last major chemical plants at risk as energy prices surge

If costs stay high for the next three months, US owner Peter Huntsman says he will close the site on Teesside

The Guardian - UK

Illegal weight loss jabs being sold in London pubs and fish and chip shops, report claims

It is alleged beauticians and personal trainers are exploiting soaring interest in weight loss jabs

Evening Standard

Feds warn Ozempic and Wegovy maker over failure to report side-effects from weight-loss drugs

Officials wrote that Novo Nordisk had failed to failed to report ‘serious and unexpected’ adverse drug experiences

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn

UK’s GSK is leading the way in research but AstraZeneca is not involved in the area, report finds

The Guardian - UK

Novo Nordisk drops lawsuit over weight loss medications, enters collaboration with online pharmacy

The news sent shares of Hims & Hers Health Inc. soaring by more than 40% in Monday morning trading

The Independent UK

Former GlaxoSmithKline HQ in west London to be transformed into 1,500 new homes

Ambitious plans to redevelop the former headquarters of GlaxoSmithKline in Brentford have been given the green light

Evening Standard

Trump administration’s embattled FDA vaccine chief departing for the second time

Vinay Prasad to leave in April after decisions involving vaccine reviews and specialty drugs for rare diseases

The Guardian - US

Navjot, Attarvir, Balwinder and Manpreet Singh charged after $2.3 million in suspected fentanyl seized in Brampton

Police have charged four men and seized more than $2.3 million worth of suspected fentanyl as part of a major drug trafficking investigation that stretched from the Greater Toronto Area to Alberta.

The Times of India

Emma Walmsley’s pay rose almost 50% to £15.6m in final year as GSK boss

Bulk of 2025 renumeration came from share bonuses as drug company’s now former CEO benefitted from stock rise

The Guardian - UK

CVS warns it could close all 134 locations in a single state if new bill goes ahead

A spokesperson for CVS Health slammed the proposal, branding it ‘bad for Tennessee’

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Novartis settles with Henrietta Lacks' estate over use of her 'stolen' cells to advance medicine

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and reproduced in labs to enable major medical advancements, including the polio vaccine

The Independent UK

FDA to offer bonus payments to staffers who complete speedy drug reviews

The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of the schedule

The Times of India

UAE urgently recalls 4 health products: What every consumer must know

UAE health authorities have urgently recalled four products, including three supplements and one medical item, due to serious safety concerns like unapproved ingredients and contamination. Consumers are warned against purchasing or using these. The recall of the supplements and health product highlights the nation's commitment to public health and strict…

The Independent UK

Novo Nordisk announces plan to cut Ozempic and Wegovy prices up to 50 percent

One in eight Americans are taking weight loss drugs like Ozempic and Wegovy

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

AstraZeneca boss Pascal Soriot’s pay rises to £17.7m

Increase of 6.4% comes as drugmaker reports strong profit growth, despite cancelling UK investment projects

The Times of India

UAE announces new pharmaceutical rule to break medicine monopolies and lower drug costs

UAE residents will find essential medicines more accessible and affordable following a landmark reform by the Emirates Drug Establishment. Effective February 24, 2026, a new rule mandates multiple authorized agents for each drug, dismantling single-agent monopolies. This move enhances supply chain flexibility, boosts competition, and strengthens the nation's healthcare sector.

Axios

The biggest challenge to Trump's drug price claims? Reality

It's unclear how many patients will actually pay less under Trump's "most favored nation" deals.

The Independent UK

FDA proposes new system for approving customized drugs and therapies for rare diseases

The Food and Drug Administration is proposing a system for approving customized drugs and medical treatments for patients with rare or hard-to-treat diseases

The Guardian - UK

Wegovy and Ozempic owner dealt blow as next-gen weight-loss drug is labelled ‘obsolete’

Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectations

The Independent UK

Warning as major shortage of painkiller used by millions could last until summer

The National Pharmacy Association (NPA) has warned the shortage could last until at least June

AAP

Biotech giant's shares dive after CEO's shock departure

Shares in Australia's largest biopharmaceutical company have hit an eight-year low after the sudden retirement of its chief executive.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

347 stories

Agency

290 stories

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.